396 Brain pathophysiology in SARS-CoV-2 disease

396 Brain pathophysiology in SARS-CoV-2 disease

OBJECTIVES/GOALS: The SARS-CoV-2 (Severe Acute Respiratory Syndrome CoronaVirus-2), which underlies the current COVID-19 pandemic, among other tissues, also targets the central nervous system (CNS). The goal of this study is to investigate mechanisms of neuroinflammation in Lipopolysaccharides (LPS)...

Full description

Bibliographic Details
Main Authors:	Branka Milicic Stanic, Aline M.A. de Souza, Hong Ji, Xie Wu, Robert C. Speth, Nisha K. Duggal, Carolyn A. Ecelbarger, Juan M. Saavedra, Dexter L. Lee, Kathryn Sandberg
Format:	Article
Language:	English
Published:	Cambridge University Press 2022-04-01
Series:	Journal of Clinical and Translational Science
Online Access:	https://www.cambridge.org/core/product/identifier/S2059866122002242/type/journal_article

Similar Items

440 Role of angiotensin II in SARS-CoV-2 pathophysiology in a hamster model of COVID-19
by: Branka Milicic Stanic, et al.
Published: (2023-04-01)

548 Metformin normalizes impaired renal and cardiac function in a rat model of transient undernutrition
by: Branka Stanic, et al.
Published: (2024-04-01)

543 The link between preexisting hypertension and COVID-19 severity in a hamster model
by: Branka Stanic, et al.
Published: (2024-04-01)

420 A novel mouse model of COVID-19
by: Branka Milicic Stanic, et al.
Published: (2023-04-01)

Sinonasal pathophysiology of SARS‐CoV‐2 and COVID‐19: A systematic review of the current evidence
by: Isabelle Gengler, et al.
Published: (2020-06-01)

Antibody Engineering Towards Enhancement of Spike Protein SARS-COV-2 -m396 Binding Affinity
by: Fateme Sefid, et al.
Published: (2021-01-01)

Pathophysiology, histopathology and therapeutic of SARS-CoV-2
by: Noman, Efaq, et al.
Published: (2020)

Comorbidity Profile and Predictors of Obstructive Sleep Apnea Severity and Mortality in Non-Obese Obstructive Sleep Apnea Patients
by: Dragana Milicic Ivanovski, et al.
Published: (2023-05-01)

Pathophysiology of SARS-CoV-2-associated ischemic stroke is variegated
by: Fulvio A. Scorza, et al.
Published: (2021-09-01)

A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy
by: Nuray Kusadasi, et al.
Published: (2020-08-01)

Heparin and SARS-CoV-2: Multiple Pathophysiological Links
by: Pierpaolo Di Micco, et al.
Published: (2021-12-01)

Pathophysiology of SARS-CoV-2 in Lung of Diabetic Patients
by: Tales Lyra Oliveira, et al.
Published: (2020-12-01)

MS Marsh 396
Published: (2021)

SARS-CoV-2-Induced Pathology—Relevance to COVID-19 Pathophysiology
by: Vsevolod A. Zinserling, et al.
Published: (2022-06-01)

Infectious SARS-CoV-2 Is Emitted in Aerosol Particles
by: Seth A. Hawks, et al.
Published: (2021-10-01)

Gastrointestinal pathophysiology of SARS-CoV2 – a literature review
by: Anwaruddin Syed, et al.
Published: (2020-11-01)

SARS-CoV-2 variants: epidemiology, pathophysiology and the importance of vaccines
by: Marcelo Bedoya-Sommerkamp, et al.
Published: (2021-11-01)

Understanding the epidemiology, pathophysiology, diagnosis and management of SARS-CoV-2
by: Adewale Oluwaseun Fadaka, et al.
Published: (2020-08-01)

THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS
by: Nicola Semeraro, et al.
Published: (2021-06-01)

Stroke Features, Risk Factors, and Pathophysiology in SARS-CoV-2–Infected Patients
by: Amir A. Mbonde, MBChB, MMed, et al.
Published: (2022-04-01)

SARS-CoV-2 and Other Respiratory Viruses in Human Olfactory Pathophysiology
by: Serigne Fallou Wade, et al.
Published: (2024-03-01)

Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination
by: Shinya Yamada, et al.
Published: (2022-03-01)

Alzheimer’s Disease and SARS-CoV-2: Pathophysiological Analysis and Social Context
by: Genaro Gabriel Ortiz, et al.
Published: (2022-10-01)

SARS-CoV-2 and Fabry nephropathy: potential risks and the pathophysiological perspective
by: Hernán Trimarchi
Published: (2020-10-01)

Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects
by: Elizabeth Griggs, et al.
Published: (2023-07-01)

Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases
by: Hamid Tanzadehpanah, et al.
Published: (2023-10-01)

Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications
by: Clara Di Vito, et al.
Published: (2022-06-01)

Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2
by: Desh Deepak Singh, et al.
Published: (2020-11-01)

Editorial: Insights in renal and epithelial physiology: 2021
by: Carolyn M Ecelbarger, et al.
Published: (2022-08-01)

Metformin and the risk of dementia based on an analysis of 396,332 participants
by: Shiliang Ji, et al.
Published: (2022-07-01)

3D Lung Tissue Models for Studies on SARS-CoV-2 Pathophysiology and Therapeutics
by: Roberto Plebani, et al.
Published: (2022-09-01)

Pathophysiological mechanisms involved in haemostatic and thromboinflammatory alterations developed by SARS-CoV-2 virus
by: Roine Alberto Pena Olivera, et al.
Published: (2023-03-01)

Virology, pathophysiology and neuroinvasion mechanisms of SARS-CoV-2: A mini literature review
by: Arash Pourgholaminejad, et al.
Published: (2021-09-01)

Alteration of Diffusion Capacity After SARS-CoV-2 Infection: A Pathophysiological Approach
by: Justine Frija-Masson, et al.
Published: (2021-03-01)

The Importance of Correlation between Aldosterone and Parathyroid Hormone in Patients with Primary Hyperparathyroidism
by: Branka Milicic Stanic, et al.
Published: (2022-01-01)

Educational initiative in an NCATS TL1 training program to address the impact of systemic racism on human health, biomedical research, and the translational scientist
by: Martha D. Gay, et al.
Published: (2022-01-01)

The Pathophysiological Relationship Between Migraine and SARS-CoV-2 Infection: A Comprehensive Literature Review
by: Noor Elkurwi, et al.
Published: (2022-12-01)

A Review on SARS-CoV-2 Virology, Pathophysiology, Animal Models, and Anti-Viral Interventions
by: Sabari Nath Neerukonda, et al.
Published: (2020-05-01)

Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung
by: Yoko Miura, et al.
Published: (2022-11-01)

Clinical implications of a mechanistic link connecting SARS-Cov-2, diabetes mellitus, Zinc in COVID-19 pathophysiology, and the prophylactics in the treatment of SARS-CoV-2
by: Deeptimayee Rout, et al.
Published: (2023-12-01)